Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetminco Regulatory News (MNC)

  • There is currently no data for MNC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of shares

6 Dec 2011 07:01

RNS Number : 4166T
Metminco Limited
06 December 2011
 



Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

 

 

Name of entity

Metminco Limited

 

ABN

43 119 759 349

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

New fully paid ordinary shares (Share)

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

Right Issue - up to 68,584,428 Shares

 

3

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

Shares issued pursuant to Rights Issue

 

 

 

 

 

 

 

 

4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes

 

 

 

5

Issue price or consideration

 

14 cents

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

 

 

 

 

The funds raised will be applied to:

 

·; pre-feasibility /scoping study at the Company's 100% owned Vallecillo exploration project

 

·; exploration, project development and working capital

 

(The Rights Issue is part of the proposed $50 million capital raising announced 25 November 2011).

 

 

 

7

Dates of entering +securities into uncertificated holdings or despatch of certificates

 

12 January 2012

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

1,674,466,146

 

 

27,217,517

 

 

Shares

 

 

December 2012 $0.25 Options

 

 

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

4,500,000

 

 

 

14,250,000

 

 

 

14,250,000

 

 

 

2,000,000

 

 

 

2,000,000

 

 

 

2,500,000

 

 

 

2,500,000

 

 

 

68,584,428

 

Options exercisable at A$0.30 expiring 31 July 12

 

Options exercisable at A$0.44 expiring no later than 6 Dec 13

 

Options exercisable at A$0.525 expiring no later than 6 Dec 13

 

Options exercisable at A$0.44 expiring 6 Dec 13

 

Options exercisable at A$0.525 expiring 6 Dec 13

 

Options exercisable at A$0.21.5 expiring no later than 5 Dec 14

 

Options exercisable at A$0.26 expiring no later than 5 Dec 14

 

Shares pursuant to Rights Issue

 

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

N/A

 

 

Part 2 ‑ Bonus issue or pro rata issue

 

11

Is security holder approval required?

 

No

 

12

Is the issue renounceable or non-renounceable?

Non-renounceable

 

13

Ratio in which the +securities will be offered

One (1) Share for every twenty (20) Shares held

14

+Class of +securities to which the offer relates

Shares

 

15

+Record date to determine entitlements

14 December 2011

 

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

No

 

17

Policy for deciding entitlements in relation to fractions

 

Rounded up to the nearest whole share

 

18

Names of countries in which the entity has +security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

All countries other than Australia and New Zealand.

 

 

19

Closing date for receipt of acceptances or renunciations

3 January 2012

20

Names of any underwriters

 

 

N/A

 

21

Amount of any underwriting fee or commission

N/A

 

22

Names of any brokers to the issue

Canaccord BGF

 

23

Fee or commission payable to the broker to the issue

2% of the total amount being offered under

the Rights Issue and a further 3% for any

shortfall Shares placed

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of +security holders

N/A

 

25

If the issue is contingent on +security holders' approval, the date of the meeting

N/A

 

26

Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled

15 December 2011

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

N/A

 

28

Date rights trading will begin (if applicable)

N/A

 

29

Date rights trading will end (if applicable)

 

 

N/A

 

30

How do +security holders sell their entitlements in full through a broker?

N/A

 

31

How do +security holders sell part of their entitlements through a broker and accept for the balance?

N/A

 

32

How do +security holders dispose of their entitlements (except by sale through a broker)?

 

 

33

+Despatch date

 

 

11 January 2012

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

 

(a)

Securities described in Part 1

 

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

Entities that have ticked box 34(a)

 Additional securities forming a new class of securities

 

 

Tick to indicate you are providing the information or documents

 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

37

A copy of any trust deed for the additional +securities

 

 

 

Entities that have ticked box 34(b)

 

38

Number of securities for which +quotation is sought

 

 

 

 

 

39

Class of +securities for which quotation is sought

 

 

 

 

 

40

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

 

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another security, clearly identify that other security)

 

 

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the securities in clause 38)

 

 

 

 

 

 

 

 

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

·; The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

·; There is no reason why those +securities should not be granted +quotation.

 

·; An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·; Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

·; If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

Sign here: Date: 06 Dec 2011

(Company secretary)

 

Print name: Philip W Killen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISUNVNRAOAURRA
Date   Source Headline
12th Oct 20185:20 pmRNSMetminco
9th Oct 20187:00 amRNSChange in Substantial Shareholding
4th Oct 20187:00 amRNSAIM delisting and Share Registry update
3rd Oct 20187:00 amRNSCapital Raising
19th Sep 20187:00 amRNSAcquisition:DSO Nickel Laterite Project-Financing
18th Sep 20188:06 amRNSASX Voluntary Suspension Update
17th Sep 20187:33 amRNSVoluntary Suspension ASX
14th Sep 20187:00 amRNSResults of EGM
13th Sep 20188:58 amRNSHalf-year Report
13th Sep 20187:30 amRNSSuspension - Metminco Limited
13th Sep 20187:13 amRNSTemporary Suspension
30th Aug 20187:00 amRNSTesorito Drilling Results
13th Aug 20187:00 amRNSGM Statement- EGM Notice of Meeting
2nd Aug 20188:25 amRNSAppointment of Exploration Director Colombia
31st Jul 20187:00 amRNSJune 30th 2018 Activity Statement & Appendix 5B
31st Jul 20187:00 amRNSTesorito Drilling Update
18th Jun 20181:55 pmRNSAppointment of Broker
5th Jun 20187:00 amRNSChange of Registered Office
5th Jun 20187:00 amRNSStrategy/Company/Ops Update
29th May 20187:00 amRNSCompany Secretary Change
29th May 20187:00 amRNSLatest Presentation
29th May 20187:00 amRNSResult of AGM
22nd May 20187:00 amRNSIssue of Equity
17th May 20188:19 amRNSLatest Presentation 121 Conference London
17th May 20187:00 amRNSHolding(s) in Company
17th May 20187:00 amRNSLatest Presentation 121 Conference London
9th May 20187:00 amRNSCeasing to be a Significant Shareholder
4th May 20188:45 amRNSChange in Holding(s) in Company
1st May 20188:25 amRNSCorporate Governance Statement
1st May 20188:03 amRNSIssue of Equity
1st May 20187:35 amRNSMarch 2018 Qtr Activities Report & App 5B
1st May 20187:00 amRNSAnnual Financial Report
26th Apr 20189:16 amRNSAGM Statement
26th Apr 20187:00 amRNSAnnouncement re: Rights Issue
20th Apr 20187:00 amRNSAnnouncement re: Rights Issue
4th Apr 201811:37 amRNSHolding(s) in Company
3rd Apr 20187:00 amRNSAnnual Financial Report
28th Mar 20187:00 amRNSIssue of Equity
27th Mar 20188:43 amRNSLatest Presentation
26th Mar 20189:00 amRNSAnnouncement re: Rights Issue
23rd Mar 20187:10 amRNSDirectorate Change
23rd Mar 20187:03 amRNSAnnouncement re: Rights Issue
23rd Mar 20187:00 amRNSAnnouncement re: Rights Issue
21st Mar 20187:00 amRNSAnnouncement re: Rights Issue
19th Mar 20187:00 amRNSDirectorate Change
14th Mar 20189:17 amRNSHolding(s) in Company
12th Mar 20187:00 amRNSAnnouncement re: Rights Issue
5th Mar 20187:00 amRNSAnnouncement re: Rights Issue
27th Feb 201810:41 amRNSStatement re Meeting 2 March 2018
8th Feb 20187:57 amRNSSubstantial Shareholder Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.